|
ATE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23840002089304E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.58949994780266E-09 |
| Normal-vs-Stage2 |
3.79660000000559E-05 |
| Normal-vs-Stage3 |
6.20969999999277E-05 |
| Normal-vs-Stage4 |
1.155920E-04 |
| Stage1-vs-Stage2 |
8.515400E-01 |
| Stage1-vs-Stage3 |
5.528200E-01 |
| Stage1-vs-Stage4 |
8.779000E-01 |
| Stage2-vs-Stage3 |
7.437600E-01 |
| Stage2-vs-Stage4 |
7.522800E-01 |
| Stage3-vs-Stage4 |
5.592200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.81750001107639E-09 |
| Normal-vs-AfricanAmerican |
4.83490000258158E-08 |
| Normal-vs-Asian |
6.40889999999894E-05 |
| Caucasian-vs-AfricanAmerican |
7.484000E-01 |
| Caucasian-vs-Asian |
4.185600E-01 |
| AfricanAmerican-vs-Asian |
4.703800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.11279907300377E-11 |
| Normal-vs-Female |
1.920120E-03 |
| Male-vs-Female |
1.437250E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.65265999999553E-05 |
| Normal-vs-Extreme_Weight |
2.72559752545476E-11 |
| Normal-vs-Obese |
1.63211999999469E-05 |
| Normal-vs-Extreme_Obese |
6.47259999999594E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.958400E-01 |
| Normal_Weight-vs-Obese |
4.604800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.603200E-01 |
| Extreme_Weight-vs-Obese |
2.111900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.559400E-01 |
| Obese-vs-Extreme_Obese |
4.440200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.043500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.47640000009086E-07 |
| Normal-vs-Age(61-80Yrs) |
2.0413004619968E-10 |
| Normal-vs-Age(81-100Yrs) |
3.15219999991179E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.952000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.508000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.309240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.606400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.504750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.580200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.29689650316823E-11 |
| Normal-VS-Type2 PRCC |
1.76968999999749E-05 |
| Normal-VS-KIRP CIMP |
2.498400E-02 |
| Normal-VS-Unclassified PRCC |
8.966300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.659800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.806000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.639600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.382200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.774600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.028400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.82569994864468E-09 |
| Normal-vs-N1 |
1.041740E-03 |
| Normal-vs-N2 |
1.817610E-03 |
| N0-vs-N1 |
8.208300E-02 |
| N0-vs-N2 |
8.543800E-01 |
| N1-vs-N2 |
3.470600E-01 |
|
|
